These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12057712)

  • 21. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.
    Panidis D; Tziomalos K; Chatzis P; Papadakis E; Delkos D; Tsourdi EA; Kandaraki EA; Katsikis I
    Eur J Endocrinol; 2013 Feb; 168(2):145-52. PubMed ID: 23109645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y
    Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
    Mirzaei F; Kazemi N
    Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
    Legro RS; Kunselman AR; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
    Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.
    Peppard HR; Marfori J; Iuorno MJ; Nestler JE
    Diabetes Care; 2001 Jun; 24(6):1050-2. PubMed ID: 11375369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution.
    Condorelli RA; Calogero AE; Di Mauro M; La Vignera S
    Gynecol Endocrinol; 2017 Sep; 33(9):665-667. PubMed ID: 28644709
    [No Abstract]   [Full Text] [Related]  

  • 33. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.
    Sawada M; Masuyama H; Hayata K; Kamada Y; Nakamura K; Hiramatsu Y
    Endocr J; 2015; 62(11):1017-23. PubMed ID: 26370557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excess mortality in mothers of patients with polycystic ovary syndrome.
    Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
    Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic beta-cells dysfunction in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Xyrafis X; Boutzios G; Christakou C
    Panminerva Med; 2008 Dec; 50(4):315-25. PubMed ID: 19078872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome.
    Rezaee M; Asadi N; Pouralborz Y; Ghodrat M; Habibi S
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):562-566. PubMed ID: 27593259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
    Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach.
    Ravn P
    Minerva Ginecol; 2015 Apr; 67(2):217-23. PubMed ID: 25668421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.